Skip to content

Efficacy of text messaging in improving care for psoriasis patients

Cardiovascular health text messages and influence on patient activation, knowledge and cardiovascular risk factors in patients with psoriasis

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12624000498594
Acronym
TEXTME PSO
Enrollment
100
Registered
2024-04-23
Start date
2024-04-29
Completion date
2024-06-11
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

Psoriasis is a chronic inflammatory skin disease that entails a significant risk of cardiovascular disease. Mitigating this risk through patient led primary and secondary prevention must be a treatment priority. This study aims to improve psoriasis patient activation (i.e. knowledge, skills and confidence), with respect to cardiometabolic health through the use of a text message intervention program, aimed at CVD prevention. We hypothesize that a structured text-messaging intervention of education- and lifestyle- targeted text messages, will improve psoriasis patient activation (knowledge, skills and confidence) regarding their health, preventative cardiovascular disease self-management and clinical outcomes compared to usual care.

Interventions

The intervention consists of educative and lifestyle based text messages aimed at CVD prevention including; diet, physical activity, smoking cessation (if relevant), weight, compliance with psoriasis treatment, general cardiovascular health information and psoriasis education, delivered over 26 weeks (approximately six months). The participants can respond to text messages, which will be relayed to study investigators and attended to as needed. They will not be encouraged to respond to messages

The intervention consists of educative and lifestyle based text messages aimed at CVD prevention including; diet, physical activity, smoking cessation (if relevant), weight, compliance with psoriasis treatment, general cardiovascular health information and psoriasis education, delivered over 26 weeks (approximately six months). The participants can respond to text messages, which will be relayed to study investigators and attended to as needed. They will not be encouraged to respond to messages. The language used in the text messages encourage behaviour change and are educational, informative, motivational and supportive in intent. In some messages links to online resources are provided for additional information or for re-enforcement. Examples of these include: links to the heart foundation website, the American academy of dermatology and dermNet. Cardiovascular health content is aligned with Australia cardiovascular health clinical practice and guidance from the National Heart Foundation. Content is all additionally reviewed by local clinicians for alignment with Australian practice. The frequency of the text messages is 4x/week. We monitor whether text messages are delivered. An end of program feedback form is also administered routinely to assess participant uptake, response and feedback.

Sponsors

Western Sydney Local Health District
Lead SponsorGovernment body

Study design

Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Prevention
Masking
Blinded (masking used) (Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Participants must meet ALL of the following inclusion criteria: • Aged 18 years or older • Have documented evidence of a diagnosis of psoriasis (chronic plaque type) by a dermatologist • Have an active mobile phone, that can receive text messages, with internet access (to be able to access educative links via text-messages) • Proficiency of the English language to consent and read text messages • Willingness and ability to provide informed consent and willingness to participate and comply with the study requirements.

Exclusion criteria

• Unable to follow up for the duration of the study due to frailty, geographical, physical or social reasons • Pregnant/Lactating women • Recent myocardial infarction, unstable angina or stroke (< 3 months)

Outcome results

None listed

Source: ANZCTR · Data processed: May 15, 2026